arrow
J

John G.F. Cleland

university of glasgow
H指数:175
被引数:19.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

改变的身体成分与接受和不接受心脏毒性治疗癌症患者中心脏消耗的关联

2026-10-070
OAAI
Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

目标剂量与低于目标剂量ACE抑制剂在美国射血分数保留的心力衰竭退伍军人中的使用:根据CKD状态区分结局

2026-07-300
PRE
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II

在假手术对照器械试验中估计安慰剂效应对患者报告结局的影响:来自REDUCE LAP-HF II的见解

2026-01-011
PRE
A double-blind, randomized placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy

一项双盲、随机安慰剂对照试验,旨在研究MitoQ对扩张型心肌病患心肌能量代谢的影响。

2025-11-010
OAAI
Neutrophil-to-Lymphocyte Ratio and Mortality in Cardiovascular Disease or Cancer A Population-Based Cohort Study

中性粒细胞与淋巴细胞比值与心血管疾病或癌症的死亡率:一项基于人群的队列研究

2025-11-010
OAAI
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure

急性心力衰竭患者残留的血管内和组织淤血的临床特征及预后影响

2025-11-010
OAAI
Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry

急性心力衰竭住院后的多药联用全球模式:来自REPORT-HF注册研究的患病率与结局

2025-10-011
OAAI